1. Home
  2. TPST vs IZEA Comparison

TPST vs IZEA Comparison

Compare TPST & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • IZEA
  • Stock Information
  • Founded
  • TPST 2011
  • IZEA 2006
  • Country
  • TPST United States
  • IZEA United States
  • Employees
  • TPST N/A
  • IZEA N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • IZEA Advertising
  • Sector
  • TPST Health Care
  • IZEA Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • IZEA Nasdaq
  • Market Cap
  • TPST 33.0M
  • IZEA 29.1M
  • IPO Year
  • TPST N/A
  • IZEA N/A
  • Fundamental
  • Price
  • TPST $6.86
  • IZEA $2.52
  • Analyst Decision
  • TPST Hold
  • IZEA
  • Analyst Count
  • TPST 3
  • IZEA 0
  • Target Price
  • TPST $30.00
  • IZEA N/A
  • AVG Volume (30 Days)
  • TPST 247.2K
  • IZEA 41.8K
  • Earning Date
  • TPST 08-07-2025
  • IZEA 08-13-2025
  • Dividend Yield
  • TPST N/A
  • IZEA N/A
  • EPS Growth
  • TPST N/A
  • IZEA N/A
  • EPS
  • TPST N/A
  • IZEA N/A
  • Revenue
  • TPST N/A
  • IZEA $36,896,490.00
  • Revenue This Year
  • TPST N/A
  • IZEA $22.24
  • Revenue Next Year
  • TPST N/A
  • IZEA N/A
  • P/E Ratio
  • TPST N/A
  • IZEA N/A
  • Revenue Growth
  • TPST N/A
  • IZEA 7.17
  • 52 Week Low
  • TPST $5.35
  • IZEA $1.68
  • 52 Week High
  • TPST $30.03
  • IZEA $3.15
  • Technical
  • Relative Strength Index (RSI)
  • TPST 49.91
  • IZEA 42.63
  • Support Level
  • TPST $6.87
  • IZEA $2.54
  • Resistance Level
  • TPST $7.25
  • IZEA $2.76
  • Average True Range (ATR)
  • TPST 0.67
  • IZEA 0.14
  • MACD
  • TPST -0.02
  • IZEA -0.05
  • Stochastic Oscillator
  • TPST 11.20
  • IZEA 14.58

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

Share on Social Networks: